Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome

Keyphrases

• Mifepristone 100%
• Cushing's Syndrome 100%
• Clinical Benefit 100%
• Glucocorticoid Receptor Antagonist 100%
• Metabolic Benefits 100%
• Diastolic Blood Pressure 50%
• Area under the Curve 50%
• Endogenous Cushing's Syndrome 50%
• Insulin Resistance 25%
• Type 2 Diabetes Mellitus (T2DM) 25%
• Quality of Life 25%
• Academic Medical Centers 25%
• Adverse Events 25%
• Edema 25%
• Clinical Status 25%
• Open-label Trial 25%
• Headache 25%
• Clinical Improvement 25%
• Vomiting 25%
• Nausea 25%
• Prolonged Exposure 25%
• Waist Circumference 25%
• Endometrial Thickening 25%
• Glycated Hemoglobin A1c 25%
• Oral Glucose Tolerance Test 25%
• Combined Modality Therapy 25%
• Glucose Response 25%
• Impaired Glucose Tolerance 25%
• Weight Change 25%
• Blood Pressure Response 25%
• Metabolic Improvement 25%
• Arthralgia 25%
• Hypertension Diagnosis 25%
• Acceptable Risk 25%
• Low Potassium 25%
• Risk-benefit 25%
• Private Research 25%
• Cortisol Levels 25%
• Fasting Blood Glucose 25%

Nursing and Health Professions

• Cushing Syndrome 100%
• Glucocorticoid Receptor Antagonist 100%
• Mifepristone 100%
• Diastolic Blood Pressure 40%
• Area under the Curve 40%
• Glucose 40%
• Insulin Resistance 20%
• Adverse Event 20%
• Morbidity 20%
• Glucose Blood Level 20%
• Hydrocortisone 20%
• University Hospital 20%
• Hemoglobin A1c 20%
• Nausea 20%
• Headache 20%
• Glucose Tolerance Test 20%
• Open-Label Trial 20%
• Glycosylated Hemoglobin 20%
• Long Term Exposure 20%
• Isotopes of Potassium 20%
• Impaired Glucose Tolerance 20%
• Edema 20%
• Waist Circumference 20%
• Arthralgia 20%
• Diseases 20%
• Quality of Life 20%
• Efficacy 20%
• Maturity Onset Diabetes of the Young 20%
• Accident Prevention 20%
• Hypertension 20%

Medicine and Dentistry

• Mifepristone 100%
• Cushing Syndrome 100%
• Glucocorticoid Receptor Antagonist 100%
• Glucose 60%
• Diastolic Blood Pressure 40%
• Area under the Curve 40%
• Maturity Onset Diabetes of the Young 20%
• Quality of Life 20%
• Hydrocortisone 20%
• Long Term Exposure 20%
• Insulin Resistance 20%
• Edema 20%
• Arthralgia 20%
• Morbidity 20%
• Headache 20%
• Hemoglobin A1c 20%
• Nausea 20%
• Open-Label Trial 20%
• Glucose Test 20%
• Glycated Hemoglobin 20%
• Impaired Glucose Tolerance 20%
• Diseases 20%
• Oral 20%
• Potassium 20%
• Hypertension 20%
• Adverse Event 20%